会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 61. 发明授权
    • Image forming apparatus including developing device and developer containing device
    • 图像形成装置包括显影装置和显影剂容纳装置
    • US06882812B2
    • 2005-04-19
    • US10367949
    • 2003-02-19
    • Nobuo KasaharaNobuo IwataSatoshi MuramatsuJunichi Matsumoto
    • Nobuo KasaharaNobuo IwataSatoshi MuramatsuJunichi Matsumoto
    • G03G21/10G03G15/08
    • G03G15/08G03G15/0896G03G2221/163G03G2221/18
    • An image forming apparatus includes a main body. The apparatus includes an image carrier, a developing device, a cleaning device that removes a waste toner on the image carrier, a developer supply device that supplies a developer to the developing device, a developer discharging device that discharges an excess developer from the developing device, and a developer containing device. The developer containing device includes an opening facing the developer supply device, a developer storing section that stores the developer supplied to the developer supply device through the opening, and a waste developer storing section that stores the excess developer and waste toner. The developer containing device is detachably attached to the main body of the image forming apparatus, and when the developer containing device is detached from the main body for replacement, the waste developer storing section is detached from the main body together with the developer containing device.
    • 图像形成装置包括主体。 该装置包括图像载体,显影装置,去除图像载体上的废调色剂的清洁装置,向显影装置供应显影剂的显影剂供应装置,从显影装置排出多余的显影剂的显影剂排出装置 ,以及开发者容纳装置。 显影剂容纳装置包括面向显影剂供应装置的开口,存储通过开口供应到显影剂供给装置的显影剂的显影剂储存部分和存储多余显影剂和废色调剂的废显影剂储存部分。 显影剂容纳装置可拆卸地附接到图像形成装置的主体,并且当显影剂容纳装置从主体拆下以进行更换时,废液显影剂储存部分与显影剂容纳装置一起从主体分离。
    • 70. 发明授权
    • Carbamoyl-2-pyrrolidinone compounds
    • 卡巴酸-2-吡咯烷酮化合物
    • US5229402A
    • 1993-07-20
    • US449923
    • 1989-12-13
    • Makoto KajitaniEtsuo HasegawaAkihiro KawaguchiJunji YamamotoKatsuo ToideTakaji HonnaMitsugi YasumotoNobuo Kasahara
    • Makoto KajitaniEtsuo HasegawaAkihiro KawaguchiJunji YamamotoKatsuo ToideTakaji HonnaMitsugi YasumotoNobuo Kasahara
    • C07D207/26C07D207/263C07D207/273C07D401/12C07D417/12
    • C07D207/27C07D207/26C07D207/273C07D401/12C07D417/12
    • The present invention provides a carbamoyl-2-pyrrolidinone compound which has the following formula (2) and is useful as medicaments for treating senile dementia, i.e., as cerebral function improving agents and cerebral metabolism activators or anoxic brain damage protectives ##STR1## wherein R.sup.1 is a hydrogen atom, hydroxyl or lower alkyl substituted or unsubstituted with hydroxyl, and R.sup.3 is phenyl, tetrahydronaphthyl, pyridyl or thiazolyl having or not having lower alkoxyl, lower alkylamino, a halogen atom or halogenomethyl as a substituent.Further, the present invention provides novel carbamoyl-2-pyrrolidinone compounds represented by the formula ##STR2## wherein R.sup.1 is a hydrogen atom, hydroxyl or lower alkyl substituted or unsubstituted with hydroxyl, and R.sup.2 is phenyl, tetrahydronaphthyl, pyridyl or thiazolyl having or not having methoxy or lower alkylamino as a substituent, provided that when R.sup.1 is a hydrogen atom or unsubstituted lower alkyl, R.sup.2 is not unsubstituted phenyl.
    • PCT No.PCT / JP89 / 00401 Sec。 371日期1989年12月13日第 102(e)日期1989年12月13日PCT提交1989年4月12日PCT公布。 公开号WO89 / 09767 本发明提供具有下式(2)的氨基甲酰基-2-吡咯烷酮化合物,可用作治疗老年痴呆的药物,即作为脑功能改善剂和脑代谢激活剂或缺氧性脑 (2)其中R1是氢原子,羟基或被羟基取代或未取代的低级烷基,R3是具有或没有低级烷氧基,低级烷基氨基,卤原子或卤代甲基的苯基,四氢萘基,吡啶基或噻唑基 作为取代基。 此外,本发明提供由式(1)表示的新型氨基甲酰基-2-吡咯烷酮化合物,其中R 1是氢原子,羟基或被羟基取代或未取代的低级烷基,R 2是苯基,四氢萘基,吡啶基或噻唑基 具有或不具有甲氧基或低级烷基氨基作为取代基,条件是当R 1为氢原子或未取代的低级烷基时,R 2为未取代的苯基。